Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Jan;114(1):49–56. doi: 10.1111/j.1476-5381.1995.tb14904.x

Characterization of the interaction between muscarinic M2 receptors and beta-adrenoceptor subtypes in guinea-pig isolated ileum.

H Reddy 1, N Watson 1, A P Ford 1, R M Eglen 1
PMCID: PMC1510155  PMID: 7712028

Abstract

1. Contraction of guinea-pig ileum to muscarinic agonists is mediated by M3 receptors, even though they account for only 30% of the total muscarinic receptor population. The aim of this study was to characterize the biochemical and functional effects of stimulation of the predominant M2 muscarinic receptor (70%) and to investigate the hypothesis that M2 receptors specifically oppose beta-adrenoceptor-mediated effects in the ileum. 2. In guinea-pig ileal longitudinal smooth muscle slices, isoprenaline, a non-selective beta-adrenoceptor agonist, and BRL 37344 (sodium-4-[2-[2-hydroxy-2-(3- chlorophenyl)ethylamino]propyl]-phenoxyacetate sesquihydrate), a beta 3-adrenoceptor selective agonist, increased cyclic AMP accumulation with -log EC50 values of 6.6 +/- 0.1 and 5.8 +/- 0.1 respectively. Maximal stimulation by BRL 37344 (10 microM) was 26.4 +/- 5.2% of that observed with isoprenaline (10 microM). Isoprenaline (10 microM)-stimulated cyclic AMP accumulation was significantly, but not completely, inhibited by propranolol (5 microM), with a propranolol-resistant component of 28.2 +/- 6.8% of the maximal stimulation to isoprenaline. In contrast, basal and BRL 37344 responses were resistant to this antagonist. These data provide evidence that both beta 1- and beta 3-adrenoceptors activate adenylyl cyclase in guinea-pig ileum. 3. Isoprenaline (10 microM)-stimulated cyclic AMP accumulation was inhibited (67.4 +/- 0.9%) by the muscarinic agonist (+)-cis-dioxolane (-log EC50 = 7.3 +/- 0.1).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
49

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvarez R., Daniels D. V. A separation method for the assay of adenylylcyclase, intracellular cyclic AMP, and cyclic-AMP phosphodiesterase using tritium-labeled substrates. Anal Biochem. 1992 May 15;203(1):76–82. doi: 10.1016/0003-2697(92)90045-9. [DOI] [PubMed] [Google Scholar]
  2. Arch J. R., Ainsworth A. T., Cawthorne M. A., Piercy V., Sennitt M. V., Thody V. E., Wilson C., Wilson S. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature. 1984 May 10;309(5964):163–165. doi: 10.1038/309163a0. [DOI] [PubMed] [Google Scholar]
  3. Arch J. R., Kaumann A. J. Beta 3 and atypical beta-adrenoceptors. Med Res Rev. 1993 Nov;13(6):663–729. doi: 10.1002/med.2610130604. [DOI] [PubMed] [Google Scholar]
  4. Berridge M. J. The interaction of cyclic nucleotides and calcium in the control of cellular activity. Adv Cyclic Nucleotide Res. 1975;6:1–98. [PubMed] [Google Scholar]
  5. Bond R. A., Clarke D. E. Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes. Br J Pharmacol. 1988 Nov;95(3):723–734. doi: 10.1111/j.1476-5381.1988.tb11698.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Caulfield M. P. Muscarinic receptors--characterization, coupling and function. Pharmacol Ther. 1993 Jun;58(3):319–379. doi: 10.1016/0163-7258(93)90027-b. [DOI] [PubMed] [Google Scholar]
  7. Challiss R. A., Adams D., Mistry R., Boyle J. P. Second messenger and ionic modulation of agonist-stimulated phosphoinositide turnover in airway smooth muscle. Biochem Soc Trans. 1993 Nov;21(4):1138–1145. doi: 10.1042/bst0211138. [DOI] [PubMed] [Google Scholar]
  8. Doods H. N., Willim K. D., Boddeke H. W., Entzeroth M. Characterization of muscarinic receptors in guinea-pig uterus. Eur J Pharmacol. 1993 Dec 7;250(2):223–230. doi: 10.1016/0014-2999(93)90385-u. [DOI] [PubMed] [Google Scholar]
  9. Drew G. M. Pharmacological characterization of the presynaptic alpha-adrenoceptors regulating cholinergic activity in the guinea-pig ileum. Br J Pharmacol. 1978 Oct;64(2):293–300. doi: 10.1111/j.1476-5381.1978.tb17303.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eglen R. M., Harris G. C. Selective inactivation of muscarinic M2 and M3 receptors in guinea-pig ileum and atria in vitro. Br J Pharmacol. 1993 Aug;109(4):946–952. doi: 10.1111/j.1476-5381.1993.tb13712.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eglen R. M., Huff M. M., Montgomery W. W., Whiting R. L. Differential effects of pertussis toxin on muscarinic responses in isolated atria and smooth muscle. J Auton Pharmacol. 1988 Mar;8(1):29–37. doi: 10.1111/j.1474-8673.1988.tb00166.x. [DOI] [PubMed] [Google Scholar]
  12. Eglen R. M., Michel A. D., Whiting R. L. Characterization of the muscarinic receptor subtype mediating contractions of the guinea-pig uterus. Br J Pharmacol. 1989 Mar;96(3):497–499. doi: 10.1111/j.1476-5381.1989.tb11843.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Eglen R. M., Reddy H., Watson N., Challiss R. A. Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol Sci. 1994 Apr;15(4):114–119. doi: 10.1016/0165-6147(94)90047-7. [DOI] [PubMed] [Google Scholar]
  14. Emorine L. J., Feve B., Pairault J., Briend-Sutren M. M., Marullo S., Delavier-Klutchko C., Strosberg D. A. Structural basis for functional diversity of beta 1-, beta 2- and beta 3-adrenergic receptors. 1991 Mar 15-Apr 1Biochem Pharmacol. 41(6-7):853–859. doi: 10.1016/0006-2952(91)90188-b. [DOI] [PubMed] [Google Scholar]
  15. Farmer J. B., Levy G. P. Differentiation of beta-adrenoreceptors by the use of blocking agents. J Pharm Pharmacol. 1970 Feb;22(2):145–146. doi: 10.1111/j.2042-7158.1970.tb08414.x. [DOI] [PubMed] [Google Scholar]
  16. Fernandes L. B., Fryer A. D., Hirshman C. A. M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. J Pharmacol Exp Ther. 1992 Jul;262(1):119–126. [PubMed] [Google Scholar]
  17. Giraldo E., Monferini E., Ladinsky H., Hammer R. Muscarinic receptor heterogeneity in guinea pig intestinal smooth muscle: binding studies with AF-DX 116. Eur J Pharmacol. 1987 Sep 23;141(3):475–477. doi: 10.1016/0014-2999(87)90568-1. [DOI] [PubMed] [Google Scholar]
  18. Grana E., Lucchelli A., Zonta F., Santagostino-Barbone M. G., D'Agostino G. Comparative studies of the postjunctional activities of some very potent muscarinic agonists. Naunyn Schmiedebergs Arch Pharmacol. 1986 Mar;332(3):213–218. doi: 10.1007/BF00504856. [DOI] [PubMed] [Google Scholar]
  19. Grassby P. F., Broadley K. J. Characterization of beta-adrenoceptors mediating relaxation of the guinea-pig ileum. J Pharm Pharmacol. 1984 Sep;36(9):602–607. doi: 10.1111/j.2042-7158.1984.tb04906.x. [DOI] [PubMed] [Google Scholar]
  20. Griffin M. T., Ehlert F. J. Specific inhibition of isoproterenol-stimulated cyclic AMP accumulation by M2 muscarinic receptors in rat intestinal smooth muscle. J Pharmacol Exp Ther. 1992 Oct;263(1):221–225. [PubMed] [Google Scholar]
  21. Kachur J. F., Sturm B. L., Gaginella T. S., Noronha-Blob L. Regulation of guinea pig ileal electrolyte transport by M3-muscarinic acetylcholine receptors in vitro. Mol Pharmacol. 1990 Dec;38(6):836–840. [PubMed] [Google Scholar]
  22. Melchiorre C., Bolognesi M. L., Chiarini A., Minarini A., Spampinato S. Synthesis and biological activity of some methoctramine-related tetraamines bearing a 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4]-benzodiazepin-6-one moiety as antimuscarinics: a second generation of highly selective M2 muscarinic receptor antagonists. J Med Chem. 1993 Nov 12;36(23):3734–3737. doi: 10.1021/jm00075a032. [DOI] [PubMed] [Google Scholar]
  23. Mian M. A., Malta E., Raper C. An homogeneous population of beta 1-adrenoceptors subserves inhibitory responses in guinea-pig ileal preparations. J Pharm Pharmacol. 1984 Oct;36(10):698–699. doi: 10.1111/j.2042-7158.1984.tb04849.x. [DOI] [PubMed] [Google Scholar]
  24. Micheletti R., Montagna E., Giachetti A. AF-DX 116, a cardioselective muscarinic antagonist. J Pharmacol Exp Ther. 1987 May;241(2):628–634. [PubMed] [Google Scholar]
  25. Mitchell R. W., Koenig S. M., Popovich K. J., Kelly E., Tallet J., Leff A. R. Pertussis toxin augments beta-adrenergic relaxation of muscarinic contraction in canine trachealis. Am Rev Respir Dis. 1993 Feb;147(2):327–331. doi: 10.1164/ajrccm/147.2.327. [DOI] [PubMed] [Google Scholar]
  26. Parker R. B., Waud D. R. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther. 1971 Apr;177(1):1–12. [PubMed] [Google Scholar]
  27. Russell J. A. Differential inhibitory effect of isoproterenol on contractions of canine airways. J Appl Physiol Respir Environ Exerc Physiol. 1984 Sep;57(3):801–807. doi: 10.1152/jappl.1984.57.3.801. [DOI] [PubMed] [Google Scholar]
  28. Soares-da-Silva P., Fernandes M. H., Pinto-do-O P. C. Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules. Br J Pharmacol. 1994 Jun;112(2):611–615. doi: 10.1111/j.1476-5381.1994.tb13118.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Thomas E. A., Baker S. A., Ehlert F. J. Functional role for the M2 muscarinic receptor in smooth muscle of guinea pig ileum. Mol Pharmacol. 1993 Jul;44(1):102–110. [PubMed] [Google Scholar]
  30. Thomas E. A., Hsu H. H., Griffin M. T., Hunter A. L., Luong T., Ehlert F. J. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues. Mol Pharmacol. 1992 Apr;41(4):718–726. [PubMed] [Google Scholar]
  31. Watson N., Eglen R. M. Effects of muscarinic M2 and M3 receptor stimulation and antagonism on responses to isoprenaline of guinea-pig trachea in vitro. Br J Pharmacol. 1994 May;112(1):179–187. doi: 10.1111/j.1476-5381.1994.tb13049.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Zhang L. B., Buxton I. L. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways. Mol Pharmacol. 1991 Dec;40(6):952–959. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES